Showing results (1-10 of 42) with videos related to
Sort By:
Pageof 5
Current Opinion in Urology|August 13, 2016
Combining chemotherapy and immune checkpoint blockadeAna Collazo-Lorduy, Matthew D GalskyFuture Oncology (London, England)|March 1, 2016
Systemic therapy for metastatic bladder cancer in 2016 and beyondAna Collazo-Lorduy, Matthew D GalskyCurrent Opinion in Pulmonary Medicine|May 7, 2024
Integrated management of stage III in nonsmall cell lung cancer: where do perioperative chemotherapy and immunotherapy fit?Ana Collazo-Lorduy, Mariola Blanco, Virginia Calvo, et al.Biomedical Optics Express|February 26, 2024
Rigid alignment method for secondary analyses of optical coherence tomography volumesAndrew Cornelio, Ana Collazo Martinez, Hanzhang Lu, et al.Methods in Molecular Biology (Clifton, N.J.)|April 2, 2016
Immunopathologic Assessment of PTEN ExpressionMireia Castillo-Martin, Tin Htwe Thin, Ana Collazo Lorduy, et al.Cancers|May 14, 2022
Unveiling the Role of the Tumor Microenvironment in the Treatment of Follicular LymphomaMariola Blanco, Ana Collazo-Lorduy, Natalia Yanguas-Casás, et al.Journal of Pediatric Urology|November 3, 2015
H-RAS mutation is a key molecular feature of pediatric urothelial bladder cancer. A detailed report of three casesMireia Castillo-Martin, Ana Collazo Lorduy, Nataliya Gladoun, et al.Lung Cancer Management|December 13, 2021
Use of immune checkpoint inhibitors in patients with solid tumors and pre-existing autoimmune or inflammatory disease: real-world dataVirginia Calvo, Marta Andrés Fernández, Ana Collazo-Lorduy, et al.Bladder Cancer (Amsterdam, Netherlands)|May 19, 2017
Survival after Metastasectomy for Metastatic Urothelial Carcinoma: A Systematic Review and Meta-AnalysisVaibhav Patel, Ana Collazo Lorduy, Aaron Stern, et al.Plos One|September 14, 2023
Examining explainable clinical decision support systems with think aloud protocolsSabrina G Anjara, Adrianna Janik, Amy Dunford-Stenger, et al.Pageof 5